AgeX Therapeutics, Inc.
AMEX:AGE
0.4302 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.005 | 0.056 | 0.046 | 0.009 | 0.01 | 0.008 | 0.009 | 0.012 | 0.005 | 0.027 | 0.024 | 0.037 | 0.056 | 0.505 | 0.434 | 0.414 | 0.515 | 0.549 | 0.411 | 0.38 | 0.388 | 0.313 | 0.38 | 0.464 | 0.239 |
| Cost of Revenue
| 0 | 0.034 | 0.033 | 0.005 | 0.001 | 0.001 | 0.005 | 0.006 | 0.001 | 0.001 | 0.002 | 0.013 | 0.003 | 0.038 | 0.05 | 0.036 | 0.034 | 0.079 | 0.049 | 0.053 | 0.063 | 0.18 | 0.078 | 0.079 | 0.109 |
| Gross Profit
| 0.005 | 0.022 | 0.013 | 0.004 | 0.009 | 0.007 | 0.004 | 0.006 | 0.004 | 0.026 | 0.022 | 0.024 | 0.053 | 0.467 | 0.384 | 0.378 | 0.481 | 0.47 | 0.362 | 0.327 | 0.325 | 0.133 | 0.302 | 0.385 | 0.13 |
| Gross Profit Ratio
| 1 | 0.393 | 0.283 | 0.444 | 0.9 | 0.875 | 0.444 | 0.5 | 0.8 | 0.963 | 0.917 | 0.649 | 0.946 | 0.925 | 0.885 | 0.913 | 0.934 | 0.856 | 0.881 | 0.861 | 0.838 | 0.425 | 1.011 | 0.83 | 0.544 |
| Reseach & Development Expenses
| 1.106 | 0.149 | 0.218 | 0.16 | 0.174 | 0.208 | 0.162 | 0.259 | 0.396 | 0.376 | 0.275 | 0.481 | 0.324 | 1.186 | 0.839 | 1.35 | 1.603 | 1.469 | 1.447 | 1.65 | 1.338 | 1.523 | 1.332 | 1.384 | 2.391 |
| General & Administrative Expenses
| 1.22 | 3.433 | 2.172 | 1.73 | 1.993 | 1.581 | 1.392 | 1.338 | 1.66 | 1.517 | 1.421 | 1.748 | 2.022 | 1.728 | 1.949 | 1.653 | 2.073 | 1.717 | 2.194 | 2.119 | 2.109 | 1.968 | 1.254 | 1.135 | 1.29 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.22 | 3.433 | 2.172 | 1.73 | 1.993 | 1.581 | 1.392 | 1.338 | 1.66 | 1.517 | 1.421 | 1.748 | 2.022 | 1.728 | 1.949 | 1.653 | 2.073 | 1.717 | 2.194 | 2.119 | 2.109 | 1.968 | 1.254 | 1.135 | 1.29 |
| Other Expenses
| 0 | 0.001 | 0.003 | 0.004 | 0.003 | 0.004 | 0.002 | 0.004 | -0.084 | 0.003 | 0.004 | 0.004 | 0.437 | 0.05 | -0.012 | -0.019 | 0.025 | 0.017 | 0.048 | 0.257 | -0.028 | 0.052 | -0.022 | 0.156 | -0.003 |
| Operating Expenses
| 2.326 | 3.582 | 2.369 | 1.89 | 2.167 | 1.789 | 1.554 | 1.597 | 2.056 | 1.893 | 1.696 | 2.229 | 2.346 | 2.914 | 2.788 | 3.003 | 3.676 | 3.186 | 3.641 | 3.769 | 3.447 | 3.491 | 2.586 | 2.519 | 3.681 |
| Operating Income
| -2.321 | -3.56 | -2.356 | -1.886 | -2.158 | -1.782 | -1.55 | -1.591 | -2.052 | -1.867 | -1.674 | -2.205 | -2.293 | -2.447 | -2.404 | -2.625 | -3.195 | -2.716 | -3.279 | -3.442 | -3.122 | -3.358 | -2.202 | -2.134 | -3.551 |
| Operating Income Ratio
| -464.2 | -63.571 | -51.217 | -209.556 | -215.8 | -222.75 | -172.222 | -132.583 | -410.4 | -69.148 | -69.75 | -59.595 | -40.946 | -4.846 | -5.539 | -6.341 | -6.204 | -4.947 | -7.978 | -9.058 | -8.046 | -10.728 | -5.795 | -4.599 | -14.858 |
| Total Other Income Expenses Net
| -7.116 | 0.102 | 0.003 | -0.001 | -1.127 | -0.979 | -0.886 | -1.027 | -0.655 | 0.003 | 0.004 | 0.004 | 0.543 | 0.05 | -0.012 | -0.019 | 0.025 | 0.017 | 0.048 | 0.257 | -0.028 | 0.052 | -0.022 | 0.156 | 3.212 |
| Income Before Tax
| -9.437 | -3.458 | -5.389 | -2.679 | -3.285 | -2.761 | -2.436 | -2.618 | -2.707 | -2.159 | -1.955 | -2.475 | -1.993 | -2.608 | -2.565 | -2.731 | -3.222 | -2.723 | -3.223 | -3.152 | -3.138 | -3.274 | -2.185 | -1.951 | -0.321 |
| Income Before Tax Ratio
| -1,887.4 | -61.75 | -117.152 | -297.667 | -328.5 | -345.125 | -270.667 | -218.167 | -541.4 | -79.963 | -81.458 | -66.892 | -35.589 | -5.164 | -5.91 | -6.597 | -6.256 | -4.96 | -7.842 | -8.295 | -8.088 | -10.46 | -5.75 | -4.205 | -1.343 |
| Income Tax Expense
| 0 | -0.002 | 3.051 | 0.786 | 2.219 | -0.057 | 0.885 | 1.027 | 0.654 | -0.01 | 0.289 | 0.277 | 0.232 | -0.15 | -0.022 | -0.042 | -0.035 | 0.018 | 0.054 | 0.003 | 0.073 | 0.141 | -0.073 | -0.048 | -0.104 |
| Net Income
| -9.437 | -3.456 | -5.401 | -2.669 | -5.504 | -2.704 | -3.321 | -3.645 | -3.361 | -2.158 | -1.955 | -2.474 | -2.088 | -2.446 | -2.543 | -2.689 | -3.187 | -2.711 | -3.221 | -3.089 | -3.133 | -3.186 | -2.151 | -1.93 | -0.235 |
| Net Income Ratio
| -1,887.4 | -61.714 | -117.413 | -296.556 | -550.4 | -338 | -369 | -303.75 | -672.2 | -79.926 | -81.458 | -66.865 | -37.286 | -4.844 | -5.859 | -6.495 | -6.188 | -4.938 | -7.837 | -8.129 | -8.075 | -10.179 | -5.661 | -4.159 | -0.983 |
| EPS
| -3.38 | -3.2 | -5.01 | -2.47 | -5.1 | -2.51 | -3.08 | -3.38 | -3.12 | -2 | -1.81 | -2.29 | -1.95 | -2.27 | -2.36 | -2.5 | -2.96 | -2.52 | -2.99 | -2.87 | -3.03 | -3.11 | -2.1 | -1.97 | -0.23 |
| EPS Diluted
| -3.38 | -3.2 | -5.01 | -2.47 | -5.1 | -2.51 | -3.08 | -3.38 | -3.12 | -2 | -1.81 | -2.29 | -1.95 | -2.27 | -2.36 | -2.5 | -2.96 | -2.52 | -2.99 | -2.87 | -3.03 | -3.11 | -2.1 | -1.89 | -0.23 |
| EBITDA
| -2.321 | -3.527 | -2.32 | -1.85 | -2.122 | -1.745 | -1.515 | -1.554 | -2.103 | -1.831 | -1.638 | -2.168 | -2.366 | -1.87 | -2.034 | -2.257 | -2.803 | -2.422 | -3.279 | -3.191 | -2.973 | -3.358 | -2.056 | -2.017 | -3.429 |
| EBITDA Ratio
| -464.2 | -62.982 | -50.435 | -205.556 | -212.2 | -218.125 | -168.333 | -129.5 | -420.6 | -67.815 | -68.25 | -58.595 | -42.25 | -3.703 | -4.687 | -5.452 | -5.443 | -4.412 | -7.978 | -8.397 | -7.662 | -10.728 | -5.411 | -4.347 | -14.347 |